June 6, 2007 - InSightec Ltd. announced that it has received CE Mark certification for its ExAblate 2000, a system that combines magnetic resonance imaging (MRI) and focused ultrasound to noninvasively treat tumors.
The system treats tumors inside the body without the need for incisions and is currently in use around the world in over 50 sites. The ExAblate 2000 is reportedly the first system to use the breakthrough MRgFUS technology that combines MRI to visualize tissues in the body, plan the treatment and monitor in real time treatment outcome and high intensity focused ultrasound to thermally ablate uterine fibroid tissue. MR thermal feedback, provided uniquely by the system, allows the physician to control and adjust the treatment in real time to ensure that the targeted tumor is fully treated and surrounding tissue is spared.
ExAblate has been recognized for its innovation and potential to serve mankind and has been awarded the 2004 European Union Information Society Technologies grand prize, The Wall Street Journal’s 2004 Technology Innovation Award and recognition as one of Advanced Imaging’s 2005 Solutions of the Year. InSightec was recently selected for the Red Herring 100 Europe 2007 list of the top privately-held technology companies in Europe, the Middle East and Africa (EMEA).
July 25, 2024 
